CompanyDeals

Jiangsu Synthgene and Starna Therapeutics Join Forces in mRNA Technology Advancement

CompanyDeals

Shanghai Escugen Partners with InxMed for Global Development Rights to EZWi-Fit Platform

CompanyDrug

RemeGen Ltd Receives FDA Clearance for MSLN-Targeting ADC RC88 in Gynecological Tumors

Policy / Regulatory

China Announces New Hospital Inspection Measures to Standardize Healthcare System

CompanyDeals

MSD Partners with Owkin to Develop MSI-H Biomarker Screening for Cancers

CompanyDeals

Sanofi Expands Oncology Portfolio with NK Cell Engager In-License from Innate Pharma

CompanyDeals

Huadong Medicine Strikes Exclusive Promotion Deal with Impact Therapeutics for Senaparib in China

CompanyDrug

Konruns Pharmaceutical Gets NMPA Approval for KC1036 Clinical Study in Juventus sarcoma

CompanyDrug

Staidson Pharmaceutical’s BDB-001 Earns Breakthrough Therapy Designation in China for AAV Treatment

CompanyDrug

3SBio Subsidiary Gets Green Light for SSGJ-608 Ankylosing Spondylitis Study

CompanyDrug

Lynk Pharmaceuticals Initiates Phase III Clinical Trial for Rheumatoid Arthritis Drug in China

CompanyDeals

Tower Cold Chain Expands into China with Partnership with Tower & Winner Solutions